Calais da Silva, Fernando <br/><br/>
Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group.  [electronic resource] 

 -  European urology  Aug 2014 
 - 232-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2013.03.055  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyproterone Acetate--administration & dosage<br/>Disease Progression<br/>Europe<br/>Humans<br/>Male<br/>Middle Aged<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Quality of Life<br/>Sexuality<br/>Survival Rate<br/>Time Factors<br/>Triptorelin Pamoate--administration & dosage